SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

APTX (APTX) News

Follow APTX (APTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol APTX Asset equity Sector Markets 90 days 5 Last 0.081 Updated Nov 12, 2026, 12:33 PM UTC Open live news feed Open APTX chart & news
M Apotex Reports Second-Quarter Results, Raises Fiscal 2027 Guidance Apotex reported second-quarter fiscal 2027 results and raised its full-year fiscal 2027 guidance. EQUITY | Nov 12, 2026, 12:33 PM UTC M Apotex Health Raises Fiscal 2027 Revenue Growth Outlook to 9%–10% Apotex Health raised its fiscal 2027 revenue growth outlook to 9%–10% after new drug launches and higher sales drove fiscal second-quarter earnings higher. EQUITY | Nov 12, 2026, 11:38 AM UTC M Apotex Reports Second-Quarter Results and Raises FY2027 Guidance Apotex reported adjusted EBITDA of $280 million with a 33% margin. It raised its FY2027 outlook to about 9–10% revenue growth and about a 31% adjusted EBITDA margin. EQUITY | Nov 12, 2026, 10:59 AM UTC L Apotex Health Corp. (APTX) Prices $1.25B Senior Unsecured Notes Apotex Health Corp. priced $1.25B in senior unsecured notes across 2029, 2031 and 2033 maturities at coupons of 4.390%, 4.769% and 5.133%, respectively. Proceeds are expected to refinance debt and for general purposes; c NEWS | Sep 28, 2026, 08:40 PM UTC L APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING Not for distribution to U.S. news wire services or dissemination in the United States.TORONTO, Sept. 28, 2026 /CNW/ -- Apotex Health Corp. (TSX:APTX) ("Apotex" or the "Company") announced today that it has priced a priva NEWS | Sep 28, 2026, 08:40 PM UTC